Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET

Andreas Eversa Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Simon Kraha Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Deniz Demira Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Ramona Gaaa Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Desislava Eltera Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Christian Schroeterb ADC and Targeted Therapeutics, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Stefan Zielonkaa Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Nicolas Rascheb ADC and Targeted Therapeutics, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Julia Dotterweichc Research Unit Oncology, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Christine Knuehlc Research Unit Oncology, Merck Healthcare KGaA, Darmstadt, GermanyView further author information

Achim Doernera Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, GermanyCorrespondence[email protected]

Your download is now in progress and you may close this window